Company profile: Scorpius Biologics
1.1 - Company Overview
Company description
- Provider of integrated CDMO services for biologics, specializing in mammalian, microbial, and cell therapies. Offers biomanufacturing from pre-clinical to commercial, including analytical methods development, process development, cGMP manufacturing, product characterization, QC release testing, formulation development, and analytical testing, supported by a clinical-scale cGMP facility.
Products and services
- Biomanufacturing Services: cGMP-compliant program spanning pre-clinical evaluation through commercial manufacturing, integrating analytical methods development, process development, product characterization, and QC release testing across mammalian, microbial, and cell therapy modalities
- Analytical Testing: validated development of analytical test methods to characterize biologics—including cell therapy products, protein therapeutics, and vaccines—ensuring product quality and consistency
- Formulation Development: biopharmaceutical-focused programs creating formulations for therapeutic proteins, enzymes, immunotoxins, monoclonal antibodies, protein-based vaccines, and cell-based therapies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scorpius Biologics
Polydex Pharmaceuticals
HQ: Canada
Website
- Description: Provider of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, manufacturing and selling dextran and derivative products to large pharmaceutical companies globally. Under a definitive supply agreement with Sparhawk in the United States, provides ferric hydroxide and hydrogenated dextran through its U.S. subsidiary, Chemdex.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Polydex Pharmaceuticals company profile →
Surepharm
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical contract manufacturing and assembly services for solid dose medicinal and healthcare products, including generic and branded formulations. Offers formulation development; tablet and hard shell capsule manufacturing to GMP; blister packing with child-resistant options; pots/bottles filling; and analytical support, pilot batch management, and stability studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surepharm company profile →
Tergus Pharma
HQ: United States
Website
- Description: Provider of end-to-end topical pharmaceutical research, drug development, testing, and manufacturing services as a CDMO, including contract R&D and commercial manufacturing for topical pharmaceuticals, plus cGMP-compliant testing services. Based in Durham, North Carolina.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tergus Pharma company profile →
Central Research Associates
HQ: United States
Website
- Description: Provider of multi-specialty clinical services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Central Research Associates company profile →
Medaspis
HQ: Germany
Website
- Description: Provider of professional expertise in healthcare, pharmaceuticals, IT, and logistics, backed by long-standing experience across these fields.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medaspis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scorpius Biologics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scorpius Biologics
2.2 - Growth funds investing in similar companies to Scorpius Biologics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scorpius Biologics
4.2 - Public trading comparable groups for Scorpius Biologics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →